SWARM ONCOLOGY LIMITED – Trademark Portfolio

Entity Type: 24

SWARM ONCOLOGY LIMITED holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SWARM. The owner is based in LONDON.

15 STUKELEY STREET, 1ST FLOOR

LONDON WC2B 5LT , GB

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SWARM
SWARM
Registered 2022

Trademark Classifications

SWARM ONCOLOGY LIMITED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does SWARM ONCOLOGY LIMITED have?

SWARM ONCOLOGY LIMITED has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does SWARM ONCOLOGY LIMITED file in?

SWARM ONCOLOGY LIMITED files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are SWARM ONCOLOGY LIMITED's most well-known trademarks?

SWARM ONCOLOGY LIMITED's registered trademark portfolio includes well-known marks such as SWARM. These are among 1 currently registered trademark in the portfolio.

What is SWARM ONCOLOGY LIMITED's trademark registration success rate?

SWARM ONCOLOGY LIMITED has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.